col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world

78 Results       Page 1

Elsevier: Lung Cancer
  original article Date Title Authors   All Authors
1 [GO] 2024―Apr―17 152 A retrospective audit comparing toxicity and survival outcomes in patients who received palliative radiotherapy for NSCLC using the COVID-19 hypofractionated regime with patients treated pre-pandemic using standard RCR recommended regimes Lynn Bell, Louise Turtle, Tony Pope, David Cobben, Anoop Haridass
2 [GO] 2024―Apr―17 101 Real-world analysis of the impact of pemetrexed in first-line maintenance (1LM) with immunotherapy (IO) for non-squamous (NSQ) advanced/metastatic non-small cell lung cancer (a/mNSCLC) lacking targetable mutations, prior to and during the COVID-19 pandemic Fabio Gomes, Niall Gilding, Vivian Tan, Katerina Christoforou, Joanne Rule, Amine Aziez, et al. (+2)
3 [GO] 2024―Apr―17 121 Ongoing impact of the pandemic on cancer services Rodanthe Nixon, Holly Emms, Carlos Pereira Chilima, Samreen Afroz, Sophie Goodrum
4 [GO] 2023―Nov―13 Disparities in outcomes between Black and White patients in North America with thoracic malignancies and COVID-19 infection (TERAVOLT) Laura Burns, Chih-Yuan Hsu, Jennifer G. Whisenant, Melina E. Marmarelis, Carolyn J. Presley, Karen L. Reckamp, et al. (+23)
5 [GO] 2023―Aug―09 Immunogenicity of COVID-19 vaccines in lung cancer patients Mariano Provencio, Anna Estival, Fernando Franco, Guillermo López-Vivanco, María Saigí, Hugo Arasanz, et al. (+24)
6 [GO] 2023―Apr―24 Real world experience of hypofractionated radical radiotherapy for non-small cell lung cancer (NSCLC) during the COVID-19 pandemic: a well-tolerated radiotherapy schedule with acceptable progression-free (PFS) and overall survival (OS) Nidhish Jeyin, Ghirmay Kidane, Dominic Withers, Simon Ball, Kathryn Tarver
7 [GO] 2023―Apr―24 Looking back at role of therapeutic bronchoscopy during the COVID-19 pandemic Matthew Wright, Amyn Bhamani, Rosalind Shea, Rimsha Khan, Ricky Thakrar, Sam Janes, Neal Navani
8 [GO] 2023―Apr―24 An integrated Allied Healthcare Professional rehabilitation service for patients with thoracic cancer: an evaluation of patient’s rehabilitations needs post COVID-19, and service improvement project Faye Dickinson, Jennie Blake, Katherine Whiteaway, Rachel Bracegirdle, Ashton Brower
9 [GO] 2023―Apr―24 Changes in diagnostic practice and stage at resection in non-small cell lung cancer during the COVID-19 pandemic: a four-year retrospective survey Chris Bell, John Gosney
10 [GO] 2023―Apr―24 The Peninsula stage III non-small cell lung cancer audit: assessing the impact of COVID-19 on treatment decisions Philippa Smith, Hannah Bond, Eleanor Weir, Benjamin Crook, Victoria Ford, Ian Fraser, et al. (+2)
11 [GO] 2023―Apr―24 Moral distress in mesothelioma and lung cancer nurses during the COVID-19 pandemic: insights from a UK survey Sarah Hargreaves, Karen Clayton, Lorraine Creech, Liz Darlison, Stephanie Ejegi-Memeh, Jackie Fenemore, et al. (+3)
12 [GO] 2023―Apr―24 Increased proportion of patients diagnosed with lung cancer as a result of an acute hospital admission during the COVID-19 pandemic, and associated inequalities Rebecca Taylor
13 [GO] 2023―Apr―24 Impact of COVID-19 lockdown on new lung cancer diagnosis at the Royal Gwent Hospital Aarij Elahi, Tanbir Kalam, Sam Williams, Alina Ionescu
14 [GO] 2023―Mar―23 How much have covid-19 pandemic waves impacted the number of lung cancer surgeries Amanda Ramos da Cunha, José Leopoldo Ferreira Antunes
15 [GO] 2022―Aug―17 The impact of COVID-19 on thoracic surgical procedures in Japan: analysis of data from the National Clinical Database Yukio Sato, Hiroyuki Yamamoto, Norihiko Ikeda, Hiroshi Konishi, Shunsuke Endo, Yoshinori Okada, et al. (+9)
16 [GO] 2022―Feb―10 Incidence and outcomes of central airway obstruction in new lung cancer diagnoses prior to and during COVID-19 Irfan Zaki, Parniya Arooj, Daniel Crowle, Alice Talbot, John Corcoran, Adrian Marchbank, et al. (+2)
17 [GO] 2022―Feb―10 The impact of COVID-19 on national targets in radical lung cancer radiotherapy: a single centre clinical audit Kimberley Durno, John Conibear
18 [GO] 2022―Feb―10 The impact of virtual lung MDT meetings (MDTMs) in response to the COVID-19 pandemic Hanna Groothuizen, Eunice Aroyewun, Magdalena Zasada, Jenny Harris, Madeleine Hewish, Cath Taylor
19 [GO] 2022―Feb―10 Impact of the COVID-19 pandemic first wave on the volume and type of systemic anticancer therapy (SACT) delivered for thoracic malignancies Marios Decatris, Nowrina Khan, Philip Ryan, Aled Phillips, Sherouk El-Batrawy, Maninder Kalkat, et al. (+5)
20 [GO] 2022―Feb―10 The effects of COVID-19 pandemic on lung cancer diagnosis Mariya Sinthiya, John Howells, Gemma Wright, Syed Mehdi
21 [GO] 2022―Feb―10 The impact of the Covid-19 pandemic on lung cancer incidence in England: an analysis of the 2019 and 2020 Rapid Cancer Registration Datasets Savannah Gysling, Helen Morgan, Onosi Ifesemen, Emma O’Dowd, David Baldwin, Doug West, et al. (+4)
22 [GO] 2022―Feb―10 The continued impact of the COVID-19 pandemic on patient advocacy and support organisations in the UK and Ireland: results from the second Global Lung Cancer Coalition (GLCC) survey Aoife McNamara, Jackie Fenemore, Jesme Fox, Matthew Peters, Sarah Winstone, Riddhi Thakrar
23 [GO] 2022―Feb―10 Impact of the COVID-19 pandemic on suspected lung cancer referrals and subsequent lung cancer diagnoses at North Bristol NHS Trust (NBT) Catherine Coombs, Adriana Pereira, Benjamin Masteman, Abiramy Jeyabalan, Martin Plummeridge, Anna Bibby
24 [GO] 2022―Feb―10 COVID-19 vaccination associated lung mass mimicking a primary lung cancer: a novel manifestation Alexandra Ostler, Georgina Keogh, William Sherwood, Thomas Newsom-Davis
25 [GO] 2022―Feb―10 Contact with lung cancer patients during COVID-19: findings from Ireland and the UK from a global survey of patient experience Aoife McNamara, Jackie Fenemore, Jesme Fox, Mike McKevitt, Riddhi Thakrar
26 [GO] 2022―Feb―10 How has the coronavirus pandemic impacted chemoradiotherapy for stage 3 non-small cell lung cancer (NSCLC) in our centre? Sangary Kathirgamakarthigeyan, Karen Foweraker, Kerstie Johnson, M. Ananth Sivanandan, Abigail Pascoe
27 [GO] 2022―Feb―10 Use of systemic anti-cancer treatments in advanced stage non-small cell lung cancer during the SARS-CoV-2 pandemic in England and Wales: an analysis of the Rapid Cancer Registration Dataset Helen Morgan, Savannah Gysling, Richard Hubbard, John Conibear, Neal Navani, David Baldwin, Emma O’Dowd
28 [GO] 2022―Feb―10 Assessment of the impact of SARS-CoV-2 PCR results amongst thoracic oncology patients Helene Greenwood, Kamalram Thippu Jayaprakash
29 [GO] 2022―Feb―10 A retrospective comparison of diagnostic pathways for lung cancer before and during the pandemic: a single UK centre experience Hannah Lawrence, Paul Beckett
30 [GO] 2021―Jul―19 An invisible group of COVID-19 victims; Impact on Dutch lung cancer care Jesper van Breeschoten, Rawa Ismail, Hans Smit, Olga Schuurbiers, Franz Schramel
31 [GO] 2021―Jul―16 Care Disruptions among Patients with Lung Cancer: A COVID-19 and Cancer Outcomes Study Sheena Bhalla, Ziad Bakouny, Andrew L. Schmidt, Chris Labaki, John A. Steinharter, Douglas A. Tremblay, et al. (+25)
32 [GO] 2021―May―28 Patient and physician opinion of virtual care in the oncology department of an Irish tertiary care centre in the era of Covid-19 Mary O’Reilly, Mark Doherty
33 [GO] 2021―May―28 Pneumomediastinum, lung cancer and Covid-19 Avinash Aujayeb
34 [GO] 2021―May―28 Stereotactic ablative body radiotherapy (SABR) lung fractionations locally in the COVID-19 era and the impact on dosimetry, resources, early toxicities, and the environment Lyndsey Phelps, Owen Morris, Nicole Dorey, Victoria Ford, Elizabeth Toy, Robert Biggar, Ian Fraser
35 [GO] 2021―May―28 Covid-19 in lung cancer patients in a DGH Avinash Aujayeb
36 [GO] 2021―May―28 The impact of COVID-19 on lung cancer diagnostics - a multicentre comparison of 2019/2020 data Neal Navani, Emma O’Dowd, Laura Succony, Berkay Karahacioglu, Robert Rintoul, Ian Woolhouse, et al. (+6)
37 [GO] 2021―May―28 Quantifying the impact of Covid-19 on lung cancer: an urgent need for restoration Emma O’Dowd, Laura Succony, Berkay Karahacioglu, Robert Rintoul, Ian Woolhouse, Matthew Evison, et al. (+6)
38 [GO] 2021―May―28 Impact of COVID-19 on mesothelioma clinical nurse specialists Bethany Taylor, Angela Tod, Clare Gardiner, Faye Forde, Lorraine Creech, Liz Darlison
39 [GO] 2021―May―28 The effect of COVID-19 on the presentation, staging, and treatment of lung cancer: a retrospective comparative audit of the ‘first wave’ Lisa Evetts, Laura Applegate, Amal Singh, Claire Johnson, Sian Wing, Bernadette McBride, et al. (+5)
40 [GO] 2021―May―28 ‘Your cough could be masking something else’ - raising awareness of lung cancer during the Covid-19 pandemic Aoife Mc Namara
41 [GO] 2021―May―28 Adapting lung cancer diagnostics during the Covid-19 pandemic Alex Bull
42 [GO] 2021―May―28 Lung cancer upstaging due to the COVID-19 pandemic Claire Vella, Asif Ashraf, Rajini Sudhir, Daniel Barnes, Jan Brozik, Praveen Rao, et al. (+12)
43 [GO] 2021―May―28 Lung cancer diagnosis: impact of the COVID-19 pandemic Sohail Ali, Rahul Dalal, Sharon Longden, Samuel Roberts, Michael Crawford
44 [GO] 2021―May―28 Anxiety and depression in lung cancer patients during Covid-19 pandemic Anitha Jacob, Rahul Mogal, Andrew Barlow, Rama Vancheeswaran
45 [GO] 2021―May―28 Evaluation of telephone consultations for follow up lung cancer patients at Royal Papworth Hospital, undertaken instead of face-to-face consultations during the Covid-19 pandemic Claire Haslop, Michael Bates, Lavinia Magee, Panagiota Chrysikaki
46 [GO] 2021―May―28 A real-world experience of second-line nivolumab in mesothelioma patients during the COVID-19 pandemic Matt Church, Paul Taylor, Yvonne Summers, Raffaele Califano, Shereen Rafee, Mairead Dixon, et al. (+2)
47 [GO] 2021―May―28 Maintaining flexible bronchoscopy and endobronchial ultrasound (EBUS) services during the COVID-19 pandemic at a tertiary centre: the Manchester Royal Infirmary experience Eman Nasr, Durgesh Rana, Nadira Narine, Haider AL-Najjar
48 [GO] 2021―May―28 Use of single-agent pembrolizumab as first-line treatment for non-small cell lung cancer with PDL1 status 50% as per NHS England interim guidance during the COVID-19 pandemic at Southend University Hospital Rebecca Sen, Rafiqul Islam Islam, Harriet Baker, Samuel Kim
49 [GO] 2021―May―28 Analysis of the source of lung cancer diagnoses during 2020 COVID-19 pandemic compared with 2015-2019 in the York and Scarborough NHS Trust Hazel Watchorn
50 [GO] 2021―May―28 Impact of the Covid-19 pandemic on a District General Hospital EBUS service Matthew Wright, Raquel d’Espiney, Jack Mulholland, Malcolm Lawson
51 [GO] 2021―May―28 The impact of the COVID-19 pandemic on lung cancer diagnosis and stage at Plymouth NHS Trust Helen McDill, Maged Hassan, Lindsey Taylor, John Corcoran, Cyrus Daneshvar
52 [GO] 2021―May―28 The impact of the COVID-19 pandemic on patient advocacy and support organisations in the UK and Ireland - results from a Global Lung Cancer Coalition (GLCC) survey Lorraine Dallas, Aoife McNamara, Matthew Peters, Riddhi Thakrar
53 [GO] 2021―May―28 The impact of the COVID-19 pandemic on pleural activity at Plymouth NHS Trust Helen McDill, Maged Hassan, Hem Rai, Avik Ghoshal, Emma Graham, Lindsey Taylor, et al. (+2)
54 [GO] 2021―May―28 The impact of the COVID-19 pandemic on referrals and diagnoses of lung cancer in a tertiary hospital Jamie Arberry, Louis Dwyer Hemmings, Jessica Gates, Jennifer Ross, Adrian Draper, Yee-Ean Ong
55 [GO] 2021―May―28 The effects of the COVID-19 pandemic on the lung cancer service at Northwick Park Hospital (NWPH) Lavanya Anandan, Priya Ramachandran, Arnab Datta, Tarangini Sathyamoorthy
56 [GO] 2021―May―28 Impact of the COVID-19 pandemic on the use of systemic anti-cancer therapy for patients diagnosed with malignancy at thoracoscopy in Aneurin Bevan University Health Board Eleanor Barton, Alina Ionescu
57 [GO] 2021―May―28 Delivering bronchoscopy and respiratory diagnostic service for lung cancer during COVID-19 pandemic: a single-centre experience Sue-Lis Yeo, Syed Muneer-ahmed, Mohammed Haris, Muhammad Ganaie, Nadeem Maddekar, Ahmad AbimusaAsa’ari, et al. (+3)
58 [GO] 2021―May―28 No evidence of increased susceptibility to COVID-19 virus among radical lung radiotherapy patients Oskar Lepiarczyk, Jonathan McAleese
59 [GO] 2021―May―28 Lung nodule management in Covid-19: does postponed surveillance matter? Ratnaprashanthika Ratnakumar, Jocelyn Fraser, Rebecca Nicholls, Jennifer Quint, Susannah Bloch
60 [GO] 2021―May―28 Emergency presentation of lung cancer: did it increase during the COVID-19? Cai Lupei, Muhammad Tariq, Imran Hussain, Nadeem Maddekar, Shahul Leyakathali khan
61 [GO] 2021―May―28 Impact of the coronavirus pandemic and national lockdown on a lung cancer service - opportunities for innovation Puneet Malhotra, Amy McIntosh, Pauline Murphy, Victoria Peers
62 [GO] 2021―May―28 The impact of SARS-COV-2 pandemic on pleural services, diagnosis of malignant effusions and junior doctors’ procedural training Nathan Riddell, Artemio Gonzales, Alina Ionescu
63 [GO] 2021―May―28 Does the use of primary care spirometry results in patients referred with suspected lung cancer have potential to avoid delays in the lung cancer referral pathway as a result of the SARS-COV-2 pandemic? Romy Ni Chleirigh, Joshua Macarthur, Sarah MacRae
64 [GO] 2021―May―28 Changes in management for patients with lung cancer referred for radical radiotherapy during the first wave of the COVID 19 pandemic in the UK (COVID-RT Lung) Kathryn Banfill Banfill, Gareth Price, Kate Wicks, Shahreen Ahmad, Hannah Bainbridge, Mike Bayne, et al. (+24)
65 [GO] 2021―May―28 Lung cancer treatment during a pandemic: how have multi-disciplinary teams changed? James Hargrave, Claire Hastings, Jackie Fenemore, Lorraine Dallas, Tom Newsom-Davis, Robert Rintoul
66 [GO] 2021―May―14 Lung Cancer Patients with COVID-19 in Spain: GRAVID study Mariano Provencio, José María Mazarico Gallego, Antonio Calles, Mónica Antoñanzas, Cristina Pangua, Xabier Mielgo Rubio, et al. (+22)
67 [GO] 2021―May―08 Impact of COVID-19 on the management of patients with thoracic cancers in a tertiary referral center Clémence Basse, Catherine Daniel, Alain Livartowski, Sophie Beaucaire-Danel, Nicolas Girard
68 [GO] 2021―May―05 Higher mortality in lung cancer patients with COVID-19? A systematic review and meta-analysis Haike Lei, Yue Yang, Wei Zhou, Mengyang Zhang, Yang Shen, Dan Tao, et al. (+4)
69 [GO] 2021―Apr―30 Safety monitoring of 2 and 4-weekly adjuvant durvalumab for patients with Stage III NSCLC; implications for the COVID-19 pandemic and beyond Kroopa Joshi, Abdul Muhith, Mariam Obeid, Charlotte Milner-Watts, Nadia Yousaf, Sanjay Popat, et al. (+4)
70 [GO] 2020―Dec―24 Evaluation of variant frequency in SARS-CoV-2 infection-related genes utilizing lung cancer genomic database Yuji Shibata, Shingo Matsumoto, Kiyotaka Yoh, Koichi Goto
71 [GO] 2020―Dec―16 Cancer treatment in the coronavirus disease pandemic Jia-Tao Zhang, Wen-Zhao Zhong, Yi-Long Wu
72 [GO] 2020―Jun―17 Checkpoint inhibitor pneumonitis mimicking COVID-19 infection during the COVID-19 pandemic Hsu-Liang Chang, Po-Ju Wei, Kuan-Li Wu, Hung-Ling Huang, Chih-Jen Yang
73 [GO] 2020―Jun―12 The treatment and outcome of a pulmonary sarcomatoid carcinoma patient infected with SARS-CoV-2 Kai Wang, Yang Liu, Tian Hu, Yumei Liu, Chao Liu
74 [GO] 2020―May―30 Covid-19 and lung cancer: A greater fatality rate? Jacobo Rogado, Cristina Pangua, Gloria Serrano-Montero, Berta Obispo, Almudena Martín Marino, Mar Pérez-Pérez, et al. (+3)
75 [GO] 2020―May―26 Optimizing lung cancer radiation treatment worldwide in COVID-19 outbreak Zhongxing Liao, Eleonor Rivin del Campo, Ahmed Salem, Qingsong Pang, Hui Liu, Jose Luis Lopez Guerra
76 [GO] 2020―May―11 Immune checkpoint inhibitors in SARS-COV-2 infected cancer patients: the spark that ignites the fire? Vincenzo Di Noia, Alessandro D’Aveni, Michela Squadroni, Giordano Berett, Giovanni Luca Ceresoli
77 [GO] 2020―May―06 Metronomic oral vinorelbine and lung cancer therapy during the COVID 19 pandemic: A single-center experience David Rossi
78 [GO] 2020―May―04 A favorable outcome of pneumonia COVID 19 in an advanced lung cancer patient with severe neutropenia: Is immunosuppression a risk factor for SARS-COV2 infection? María Sereno, Gerardo Gutiérrez-Gutiérrez, Carmen Sandoval, Sandra Falagan, Ana María Jimenez-Gordo, María Merino, et al. (+4)

78 Results       Page 1


Last change 2023―Oct―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.015 sec